SCHEMBL5815219

SCHEMBL5815219

CCc1nc(-c2cccc(Cl)c2)c(-c2ccnc([S+](C)[O-])n2)s1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 19/20 0.52
TGFBR1 P36897 1/20 0.42
IKBKB O14920 1/20 0.40
MAPK13 O15264 1/20 0.40
PRKD3 O94806 1/20 0.40
MAP4K4 O95819 1/20 0.40
EGFR P00533 1/20 0.40
MAPK1 P28482 1/20 0.40
FLT4 P35916 1/20 0.40
KDR P35968 1/20 0.40
FRK P42685 1/20 0.40
MAPK8 P45983 1/20 0.40
MAPK9 P45984 1/20 0.40
CSNK1A1 P48729 1/20 0.40
CSNK1D P48730 1/20 0.40
CSNK1E P49674 1/20 0.40
MAPK12 P53778 1/20 0.40
CSNK1G2 P78368 1/20 0.40
PTK6 Q13882 1/20 0.40
ERBB4 Q15303 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5812694 0.85 TGFBR1 (0.59) MAPK14TGFBR1MAP4K4MAPK1
SCHEMBL5819199 0.81 MAPK14 (0.52) MAPK14TGFBR1IKBKBMAPK13PRKD3
SCHEMBL5817042 0.81 RORB (0.38) MAPK14TGFBR1MAP4K4
SCHEMBL5819156 0.79 HPGD (0.42) MAPK14TGFBR1
SCHEMBL3890057 0.76 MAPK14 (0.77) MAPK14IKBKBMAPK13PRKD3MAP4K4
SCHEMBL5780175 0.75 ADORA2A (0.36) MAPK14TGFBR1MAPK1
SCHEMBL3890883 0.75 MAPK14 (0.77) MAPK14IKBKBMAPK13PRKD3MAP4K4
SCHEMBL5819562 0.75 MAPK14 (0.52) MAPK14MAPK13MAPK12MAPK11
SCHEMBL5819565 0.75 MAPK14 (0.52) MAPK14MAPK13MAPK12MAPK11
SCHEMBL5815501 0.75 NOS1 (0.42) MAPK14MAP4K4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006137658-A1 NEW SUBSTITUTED 1,3-THIAZOLE DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF HAVING IMMUNOSUPPRESSION AND INFLAMMATION INHIBITORY ACITIVITY, INTERMEDIATE COMPOUNDS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, A PROCESS FOR THE PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME DONGBU HITEK CO., LTD. (KR) 2006-12-28 WO claimed
WO-2006137658-A1 NEW SUBSTITUTED 1,3-THIAZOLE DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF HAVING IMMUNOSUPPRESSION AND INFLAMMATION INHIBITORY ACITIVITY, INTERMEDIATE COMPOUNDS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, A PROCESS FOR THE PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME DONGBU HITEK CO., LTD. (KR) 2006-12-28 WO disclosed